Sterile fill-finish and lyophilisation
Sterile fill-finish is putting the finished drug into vials under sterile conditions. It is a frequent cause of shortages when capacity is tight.
Fill-finish capacity for biologics, ADCs, and radiopharmaceutical kits is concentrated (Catalent, Vetter, Baxter BioPharma Solutions, Thermo Fisher, Lonza, Samsung Biologics); lyophilisation is common for ADCs and mRNA products. Shortages of cisplatin and carboplatin in 2023 traced to a single sterile injectables plant (Intas/Accord) failing inspection, exposing the fragility of generic oncology supply.
How it works
Fill-finish relies on aseptic filling in isolators, lyophilisation cycles tuned to product stability, and 100% container-closure integrity inspection.
- Established GMP
- Concentrated capacity
- Generic injectable shortages
- Long qualification times
Latest papers
topQuery for this technology: (TITLE:"Sterile fill-finish and lyophilisation" OR ABSTRACT:"Sterile fill-finish and lyophilisation") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Sterile fill-finish and lyophilisation, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyViral vector manufacturing (lentiviral, retroviral, AAV)
Shares Catalent (Novo Holdings), CDMO (contract development and manufacturing organisation), Lonza, Thermo Fisher Scientific and the tag supporting.
- TechnologyADC bioconjugation manufacturing (CDMOs)
Shares Samsung Biologics, CDMO (contract development and manufacturing organisation), Lonza, Antibody manufacturing (CHO bioprocessing) and the tag supporting.
- CompanyCivica Rx
Shares Generic oncology drug supply and shortage mitigation and the tag supporting.
- CompanyBoehringer Ingelheim BioXcellence
Shares Antibody manufacturing (CHO bioprocessing) and the tag supporting.
- CompanyFUJIFILM Diosynth Biotechnologies
Shares Antibody manufacturing (CHO bioprocessing) and the tag supporting.
- TechnologyPayload-linker synthesis (high-potency API)
Shares Lonza, Antibody-drug conjugate (ADC) and the tag supporting.
- CompanyFresenius Kabi
Shares Generic oncology drug supply and shortage mitigation and the tag supporting.
- TechnologyHigh-throughput screening and DNA-encoded libraries
Shares Thermo Fisher Scientific and the tag supporting.